rs1801023

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP2BA1

This summary comes from the ClinGen Evidence Repository: The c.345G>A variant has an allele frequency of 0.007677 (0.77%, 235/30,612 alleles, 4 homozygotes) in the South Asian subpopulation of the gnomAD cohort (BA1, BP2). Therefore, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): BA1, BP2. LINK:https://erepo.genome.network/evrepo/ui/classification/CA293902/MONDO:0007648/007

Frequency

Genomes: 𝑓 0.0026 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 25 hom. )

Consequence

CDH1
NM_004360.5 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel B:24

Conservation

PhyloP100: -5.60

Publications

11 publications found
Variant links:
Genes affected
CDH1 (HGNC:1748): (cadherin 1) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015]
CDH1 Gene-Disease associations (from GenCC):
  • blepharocheilodontic syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • CDH1-related diffuse gastric and lobular breast cancer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • hereditary diffuse gastric adenocarcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • cleft soft palate
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • orofacial cleft 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • blepharocheilodontic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004360.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
NM_004360.5
MANE Select
c.345G>Ap.Thr115Thr
synonymous
Exon 3 of 16NP_004351.1A0A0U2ZQU7
CDH1
NM_001317184.2
c.345G>Ap.Thr115Thr
synonymous
Exon 3 of 15NP_001304113.1P12830-2
CDH1
NM_001317185.2
c.-1271G>A
5_prime_UTR
Exon 3 of 16NP_001304114.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
ENST00000261769.10
TSL:1 MANE Select
c.345G>Ap.Thr115Thr
synonymous
Exon 3 of 16ENSP00000261769.4P12830-1
CDH1
ENST00000422392.6
TSL:1
c.345G>Ap.Thr115Thr
synonymous
Exon 3 of 15ENSP00000414946.2P12830-2
CDH1
ENST00000562836.5
TSL:1
n.416G>A
non_coding_transcript_exon
Exon 2 of 15

Frequencies

GnomAD3 genomes
AF:
0.00262
AC:
398
AN:
152168
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000434
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.00836
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00787
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00388
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00372
AC:
933
AN:
251082
AF XY:
0.00417
show subpopulations
Gnomad AFR exome
AF:
0.000615
Gnomad AMR exome
AF:
0.00208
Gnomad ASJ exome
AF:
0.0105
Gnomad EAS exome
AF:
0.000217
Gnomad FIN exome
AF:
0.000601
Gnomad NFE exome
AF:
0.00414
Gnomad OTH exome
AF:
0.00376
GnomAD4 exome
AF:
0.00373
AC:
5456
AN:
1461852
Hom.:
25
Cov.:
32
AF XY:
0.00383
AC XY:
2786
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.000538
AC:
18
AN:
33480
American (AMR)
AF:
0.00233
AC:
104
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00976
AC:
255
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.00827
AC:
713
AN:
86256
European-Finnish (FIN)
AF:
0.000562
AC:
30
AN:
53418
Middle Eastern (MID)
AF:
0.0113
AC:
65
AN:
5762
European-Non Finnish (NFE)
AF:
0.00362
AC:
4020
AN:
1111984
Other (OTH)
AF:
0.00411
AC:
248
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
311
623
934
1246
1557
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00261
AC:
397
AN:
152286
Hom.:
3
Cov.:
32
AF XY:
0.00282
AC XY:
210
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.000433
AC:
18
AN:
41556
American (AMR)
AF:
0.00216
AC:
33
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00836
AC:
29
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00767
AC:
37
AN:
4824
European-Finnish (FIN)
AF:
0.000377
AC:
4
AN:
10606
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00388
AC:
264
AN:
68030
Other (OTH)
AF:
0.00473
AC:
10
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
20
41
61
82
102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00347
Hom.:
1
Bravo
AF:
0.00250
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.00491
EpiControl
AF:
0.00533

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
10
not specified (10)
-
-
5
Hereditary diffuse gastric adenocarcinoma (5)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
-
3
not provided (3)
-
-
1
CDH1-related diffuse gastric and lobular breast cancer syndrome (1)
-
-
1
Malignant tumor of breast (1)
-
-
1
Prostate cancer (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.47
DANN
Benign
0.58
PhyloP100
-5.6
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1801023; hg19: chr16-68835754; API